LifeMD, Inc.
LFMD
$3.84
-$0.09-2.29%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 251.23M | 244.33M | 235.15M | 213.59M | 194.20M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 251.23M | 244.33M | 235.15M | 213.59M | 194.20M |
| Cost of Revenue | 32.91M | 30.52M | 28.11M | 24.07M | 19.99M |
| Gross Profit | 218.32M | 213.81M | 207.03M | 189.52M | 174.20M |
| SG&A Expenses | 198.34M | 196.90M | 193.69M | 185.51M | 174.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 9.73M | 8.93M | 7.95M | 7.92M | 7.01M |
| Total Operating Expenses | 251.66M | 246.78M | 239.85M | 227.01M | 210.80M |
| Operating Income | -428.20K | -2.46M | -4.70M | -13.41M | -16.60M |
| Income Before Tax | -3.75M | -4.92M | -7.03M | -15.60M | -18.80M |
| Income Tax Expenses | 338.60K | 402.00K | 402.00K | 402.00K | 660.50K |
| Earnings from Continuing Operations | -4.09 | -5.32 | -7.43 | -16.00 | -19.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.63M | -1.25M | -990.40K | -578.00K | -746.90K |
| Net Income | -5.72M | -6.57M | -8.42M | -16.58M | -20.20M |
| EBIT | -428.20K | -2.46M | -4.70M | -13.41M | -16.60M |
| EBITDA | 1.37M | -794.50K | -3.14M | -11.94M | -15.24M |
| EPS Basic | -0.20 | -0.23 | -0.28 | -0.48 | -0.59 |
| Normalized Basic EPS | -0.07 | -0.10 | -0.13 | -0.25 | -0.31 |
| EPS Diluted | -0.20 | -0.23 | -0.28 | -0.49 | -0.59 |
| Normalized Diluted EPS | -0.07 | -0.10 | -0.13 | -0.25 | -0.31 |
| Average Basic Shares Outstanding | 175.93M | 171.79M | 168.67M | 164.78M | 159.31M |
| Average Diluted Shares Outstanding | 178.38M | 174.24M | 171.12M | 164.78M | 159.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -54.35% | -47.30% | -36.88% | -18.74% | -15.38% |